Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (487) 487
Newspaper Article (10) 10
Book / eBook (6) 6
Book Chapter (4) 4
Book Review (3) 3
Web Resource (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (307) 307
science & technology (283) 283
life sciences & biomedicine (276) 276
female (214) 214
male (214) 214
gastroenterology & hepatology (184) 184
middle aged (184) 184
adult (175) 175
biological and medical sciences (145) 145
medical sciences (138) 138
hepatitis c, chronic - drug therapy (116) 116
antiviral agents - therapeutic use (109) 109
hepatitis c (83) 83
drug therapy, combination (81) 81
hepacivirus - genetics (78) 78
aged (77) 77
interferon-alpha - therapeutic use (75) 75
recombinant proteins (75) 75
infectious diseases (71) 71
ribavirin - therapeutic use (68) 68
treatment outcome (68) 68
abridged index medicus (66) 66
viral diseases (65) 65
human viral diseases (64) 64
viral hepatitis (64) 64
genotype (56) 56
polyethylene glycols - therapeutic use (55) 55
gastroenterology. liver. pancreas. abdomen (53) 53
pharmacology. drug treatments (53) 53
antiviral agents (51) 51
gastroenterology and hepatology (51) 51
interferon (50) 50
ribavirin (47) 47
hepatitis (46) 46
hepatitis c virus (44) 44
liver - pathology (42) 42
care and treatment (41) 41
antiviral agents - adverse effects (40) 40
cirrhosis (40) 40
rna, viral - blood (40) 40
adolescent (39) 39
antiviral agents - administration & dosage (39) 39
hepatitis c, chronic - virology (39) 39
liver. biliary tract. portal circulation. exocrine pancreas (39) 39
health aspects (38) 38
prospective studies (37) 37
retrospective studies (36) 36
risk factors (35) 35
double-blind method (34) 34
fibrosis (34) 34
drug therapy (33) 33
liver (33) 33
alanine transaminase - blood (32) 32
antibiotics. antiinfectious agents. antiparasitic agents (31) 31
biopsy (31) 31
interferon-alpha - administration & dosage (31) 31
liver diseases (31) 31
transplantation (31) 31
liver transplantation (30) 30
ribavirin - administration & dosage (30) 30
general & internal medicine (29) 29
medicine, general & internal (29) 29
smoking (29) 29
surgery (29) 29
time factors (29) 29
young adult (29) 29
clinical trials (28) 28
ribavirin - adverse effects (28) 28
hepacivirus - drug effects (27) 27
viral load (27) 27
disease progression (26) 26
hepatitis c, chronic - complications (26) 26
interferon-alpha - adverse effects (26) 26
recurrence (26) 26
hepacivirus - isolation & purification (25) 25
patients (25) 25
analysis (24) 24
follow-up studies (24) 24
dose-response relationship, drug (23) 23
drug administration schedule (23) 23
hepatitis c, chronic - pathology (22) 22
other diseases. semiology (22) 22
hepatitis c - drug therapy (21) 21
hepatology (21) 21
liver cirrhosis - pathology (21) 21
liver cirrhosis - virology (21) 21
pharmacology & pharmacy (21) 21
liver cirrhosis (20) 20
liver cirrhosis - complications (20) 20
research (20) 20
recombinant proteins - therapeutic use (19) 19
social sciences (19) 19
substance abuse (19) 19
aged, 80 and over (18) 18
genotype & phenotype (18) 18
hepatitis c, chronic - blood (18) 18
medicine & public health (18) 18
polyethylene glycols - administration & dosage (18) 18
smoking - psychology (18) 18
genetic aspects (17) 17
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Outcome of sustained virological responders with histologically advanced chronic hepatitis C
by Morgan, Timothy R and Ghany, Marc G and Kim, Hae‐Young and Snow, Kristin K and Shiffman, Mitchell L and De Santo, Jennifer L and Lee, William M and Di Bisceglie, Adrian M and Bonkovsky, Herbert L and Dienstag, Jules L and Morishima, Chihiro and Lindsay, Karen L and Lok, Anna S. F and HALT-C Trial Grp and HALT-C Trial Group and and the HALT-C Trial Group
Hepatology (Baltimore, Md.), ISSN 0270-9139, 09/2010, Volume 52, Issue 3, pp. 833 - 844
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Viral hepatitis | Infectious diseases | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Recurrence | Carcinoma, Hepatocellular - epidemiology | Liver - pathology | Prognosis | Prospective Studies | Follow-Up Studies | United States | Humans | Middle Aged | Male | Recombinant Proteins | Hepatitis C, Chronic - mortality | Polyethylene Glycols - therapeutic use | Liver Neoplasms - epidemiology | Adult | Female | Severity of Illness Index | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Risk Factors | Interferon-alpha - therapeutic use | Survival Rate | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Disease Progression | Interferon alpha-2 | Cohort Studies | Hepatitis | Transplants & implants | Liver cirrhosis | Mortality | Index Medicus | hepatitis C treatment | survival analysis | hepatocellular carcinoma | peginterferon
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Selected Summary
by Shiffman, Mitchell L
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 01/2018, Volume 154, Issue 1, pp. 253 - 254
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Approach to the patient with chronic hepatitis B and decompensated cirrhosis
by Shiffman, Mitchell L
Liver international, ISSN 1478-3223, 02/2020, Volume 40, Issue S1, pp. 22 - 26
chronic hepatitis B | HBV DNA | non‐alcoholic fatty liver disease | cirrhosis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Antigens | Therapy | Alanine | Liver diseases | Transplants & implants | Syngeneic grafts | Liver | Mortality | Chronic infection | Viruses | Hepatocellular carcinoma | Transplantation | Cirrhosis | Hepatitis | Fatty liver | Allografts | Fibrosis | Alanine transaminase | Interferon | Hepatitis B virus | Hepatitis B | Liver transplantation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
by McHutchison, John G and Lawitz, Eric J and Shiffman, Mitchell L and Muir, Andrew J and Galler, Greg W and McCone, Jonathan and Nyberg, Lisa M and Lee, William M and Ghalib, Reem H and Schiff, Eugene R and Galati, Joseph S and Bacon, Bruce R and Davis, Mitchell N and Mukhopadhyay, Pabak and Koury, Kenneth and Noviello, Stephanie and Pedicone, Lisa D and Brass, Clifford A and Albrecht, Janice K and Sulkowski, Mark S and IDEAL Study Team
The New England journal of medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 6, pp. 580 - 593
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Hepacivirus - isolation & purification | Double-Blind Method | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Genotype | Male | RNA, Viral - blood | Recombinant Proteins | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Dose-Response Relationship, Drug | Interferon-alpha - administration & dosage | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Ribavirin - administration & dosage | Female | Interferon-alpha - adverse effects | Drug Therapy, Combination | Hepatitis | Medical research | Liver diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The next wave of hepatitis C virus: The epidemic of intravenous drug use
by Shiffman, Mitchell L
Liver international, ISSN 1478-3223, 02/2018, Volume 38, Issue S1, pp. 34 - 39
HCV treatment | chronic HCV | persons who inject drugs | Antiviral agents | Epidemics | Baby boom generation | Social aspects | Hepatitis C virus | Blood donors | Drugs | Drug abuse | Intravenous administration | Liver | Viruses | Hepatocellular carcinoma | Transplantation | Blood transfusion | Blood | Immunosuppressive agents | Hepatitis | Cirrhosis | Demographics | Social problems | Baby boomers | Hepatitis C | Social conditions | Drug use | Liver transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Clinical practice guideline: Adult sinusitis
by Rosenfeld, Richard M and Andes, David and Bhattacharyya, Neil and Cheung, Dickson and Eisenberg, Steven and Ganiats, Theodore G and Gelzer, Andrea and Hamilos, Daniel and Haydon, Richard C and Hudgins, Patricia A and Jones, Stacie and Krouse, Helene J and Lee, Lawrence H and Mahoney, Martin C and Marple, Bradley F and Mitchell, Col. John P and Nathan, Robert and Shiffman, Richard N and Smith, Timothy L and Witsell, David L
Otolaryngology--head and neck surgery, ISSN 0194-5998, 2007, Volume 137, Issue 3, pp. S1 - S31
Otorhinolaryngology | Life Sciences & Biomedicine | Surgery | Science & Technology | Acute Disease | Humans | Adult | Evidence-Based Medicine | Chronic Disease | Sinusitis - drug therapy | Practice Guidelines as Topic | Practice guidelines (Medicine) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
by Poordad, Fred and Hezode, Christophe and Trinh, Roger and Kowdley, Kris V and Zeuzem, Stefan and Agarwal, Kosh and Shiffman, Mitchell L and Wedemeyer, Heiner and Berg, Thomas and Yoshida, Eric M and Forns, Xavier and Lovell, Sandra S and Da Silva-Tillmann, Barbara and Collins, Christine A and Campbell, Andrew L and Podsadecki, Thomas and Bernstein, Barry
The New England journal of medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 21, pp. 1973 - 1982
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | General aspects | Viral hepatitis | Infectious diseases | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Other diseases. Semiology | Recurrence | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Male | Hepatitis C, Chronic - complications | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Genotype | Logistic Models | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Complications and side effects | Evaluation | Care and treatment | Usage | Hepatitis C | Liver cirrhosis | Ribavirin | Headache | Antiviral agents | Ritonavir | Body weight | Fatigue | Infections | Nausea | Proteinase inhibitors | RNA polymerase | Patients | Cirrhosis | Liver cancer | Genotype & phenotype | Hepatitis | Hemoglobin | Interferon | Drug therapy | Genotypes | Index Medicus | Abridged Index Medicus | Cirrosi hepàtica | Inhibidors enzimàtics | Enzyme inhibitors | Hepatic cirrhosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights